NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Instruments & Supplies · USD

Baxter International Inc. (BAX) Stock Analysis

Baxter International Inc. (BAX) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

BAX

$24.70

+$0.19 (+0.78%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BAX with… →

BAX Key Statistics

As of Oct 21, 2026
Trading
Open
$24.36
Previous Close
$24.51
Day's Range
24.29–24.83
52-Week Range
15.73–30.00
Volume
5.38M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.65
Valuation
Market Cap
$12.67B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
12.02
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
36.68
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.10
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.88
Financials (FY)
Revenue (FY)
$11.24B+5.72%
Net Income (FY)
−$957.00M
Profit marginThe share of revenue left as profit after all costs and taxes.
−9.27%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
517.00M
1-Year Return
+8.78%
Dividend and dates
Dividend
$0.04+0.16%
Ex-Dividend Date
August 28, 2026
Earnings Date
October 29, 2026
Avg Volume
6.51M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, BAX closed at $24.70, +8.78% over 1 year.

Baxter International Inc. (BAX) has a market capitalization of $12.67B.

In fiscal 2025, BAX reported revenue of $11.24B.

BAX Stock Return by Calendar Year

Baxter International Inc. (BAX) 10-year return: what $10,000 became

1 year
$10,000 $10,878
+8.78%
5 years
$10,000 $3,345
−66.55%
10 years
$10,000 $5,979
−40.21%

If you had invested $10,000 in Baxter International Inc. (BAX) 10 years ago, at the close on October 21, 2016, it would have been worth $5,979 at the close on October 21, 2026: −40.21% in total, −5.01% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+29.43%
2025−33.28%
2024−22.40%
2023−21.91%
2022−39.58%
2021+8.48%
2020−2.95%
2019+28.40%
2018+2.89%
2017+47.30%
2016 (partial year)−7.10%

As of October 21, 2026.

BAX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$11.24B−$957.00M−8.5%
2024$10.64B−$649.00M−6.1%
2023$10.36B$2.66B25.6%
2022$10.06B−$2.43B−24.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$11.24B$3.38B$177.00M−$957.00M−8.5%
2024$10.64B$3.98B$439.00M−$649.00M−6.1%
2023$10.36B$4.15B$707.00M$2.66B25.6%
2022$10.06B$3.55B−$33.00M−$2.43B−24.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BAX Dividend History

$0.52−50.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.033—
2025$0.524−50.0%
2024$1.044−10.3%
2023$1.164+0.9%
YearDividends per sharePaymentsChange
2026 (partial year)$0.033—
2025$0.524−50.0%
2024$1.044−10.3%
2023$1.164+0.9%
2022$1.154+6.0%
2021$1.094+13.6%
2020$0.964+12.4%
2019$0.854+16.4%
2018$0.734+19.7%
2017$0.614+369.2%
2016$0.131—

Most recent payment: $0.01 per share, ex-dividend August 28, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

BAX Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricBAXMedical Instruments & Supplies medianvs median
P/S ratio1.102.6057% below
Profit margin−9.27%1.62%10.9 pts below

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Baxter International Inc. (BAX) at $12.67B. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 37,500.

Over the past 52 weeks the price has ranged from $15.73 to $30.00. BAX last closed at $24.70 on October 21, 2026. That is +$0.19 (+0.78%) against the previous close. The latest close sits 57.02% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $11.24B. That is +5.72% against the prior fiscal year, when revenue was $10.64B. The same year closed with a net loss of $957.00M. The reported profit margin is −9.27%. That is 10.9 percentage points below the Medical Instruments & Supplies median of 1.62%. Trailing earnings per share are −1.88.

Across the 4 fiscal years on file, revenue moves from $10.06B in 2022 to $11.24B in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 12.02. The PEG ratio, which sets the P/E against expected earnings growth, reads 36.68. The price-to-sales ratio is 1.1. On price-to-sales that is 57.47% below the Medical Instruments & Supplies median of 2.6. The medians here are taken across 50 Medical Instruments & Supplies companies that report the metric.

Beta against the wider market is reported at 0.65. Annualized volatility over the trailing 10 years is 29.94%. Over the trailing twelve months the total return is +8.78%. Across 10 years the annualized return works out at −5.01%.

Growth & Income

The trailing dividend yield is 0.16%. That is 0.9 percentage points below the Medical Instruments & Supplies median yield of 1.04%. At the indicated rate that is $0.04 a share a year. The ex-dividend date on file is August 28, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $0.03 a share. The year before, 2025, totalled $0.52 a share.

The strongest complete calendar year on file is 2017 at +47.30%; the weakest is 2022 at −39.58%. Of the 9 complete calendar years on file, 4 finished higher. 2026 is still running; the total return is +29.43% year to date.

Peer Comparison

Baxter International Inc. (BAX) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Baxter International Inc. BAX $12.67B —
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Baxter International Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Visit website →